The Institute for Advanced Clinical Trials for Children (IACT4C) is a 501(c)3 non-profit organization established to drive innovation to improve and expedite pediatric drug development. The organization's work focuses on providing children with medical conditions a better chance at a high quality of life through the development of safe and effective new drugs, addressing the long-standing pediatric gap in drug approvals.
2016
81-2076517
$5.456 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
A bold initiative to significantly reduce the time it takes to develop drugs for pediatric patients.
Heartfelt stories highlighting the urgency and impact of pediatric drug development.
A program designed to enhance competency in pediatric research through mentorship.
The 9 to 5 Project
Initiative aimed at reducing the pediatric drug development timeline from an average of 9 years to 5 years.
Overall Score
61
40
/100
Program Expense Ratio
62.42%
6
/20
Program Revenue Growth
-23.44%
2
/20
Leverage Ratio
0.04736
20
/20
Working Capital Ratio
1.018
10
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 2.354M | 71.90% |
Program Services | 935.1K | 28.56% |
Investment Income | 19.94K | 0.61% |
Sales of Non-Inventory Assets | -35.07K | -1.07% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 3.274M | 100.00% |
Med Research
Children Health ResearchMed Research
Children Health ResearchMed Research
Children Health ResearchMed Research
Children Health ResearchMed Research
Children Health Research